LAUREN YORK: Open Payments
NPI 1790234524 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 18 payments from 12 companies in 2025. Trend: 2023 $1,451 · 2024 $1,328 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 3 | $60 |
| ABBVIE INC. | 2 | $50 |
| Abbott Laboratories | 2 | $44 |
| Novo Nordisk Inc | 2 | $41 |
| Amgen Inc. | 2 | $33 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ABIOMED | 1 | $18 |
Products named: APRETUDE, LINZESS, FREESTYLE LIBRE 3, Wegovy, ZENPEP, KEVEYIS, CAPVAXIVE, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
